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ABSTRACT
Objective: To study the temporal relationship of
smoking with electrophysiological changes.
Design: Prospective observational study.
Setting: Tertiary cardiac center.
Participants: Male smokers with atypical chest pain
were screened with a treadmill exercise test (TMT).
A total of 31 such patients aged 49.8±10.5 years, in
whom TMT was either negative or mildly positive were
included. Heart rate variability (HRV) parameters of
smokers were compared to those of 15 healthy non-
smoking participants.
Interventions: All patients underwent a 24 h Holter
monitoring to assess ECG changes during smoking
periods.
Results: Heart rate increased acutely during smoking.
Mean heart rate increased from 83.8±13.7 bpm 10 min
before smoking, to 90.5±16.4 bpm during smoking,
(p<0.0001) and returned to baseline after 30 min.
Smoking was also associated with increased ectopic
beats (mean of 5.3/h prior to smoking to 9.8/h during
smoking to 11.3/h during the hour after smoking;
p<0.001). Three patients (9.7%) had significant ST–T
changes after smoking. HRV index significantly
decreased in smokers (15.2±5.3) as compared to non-
smoking controls participants (19.4±3.6; p=0.02), but
the other spectral HRV parameters were comparable.
Conclusions: Heart rate and ectopic beats increase
acutely following smoking. Ischaemic ST–T changes
were also detected during smoking. Spectral
parameters of HRV analysis of smokers remained in
normal limits, but more importantly geometrical
parameter—HRV index—showed significant
abnormality.
INTRODUCTION
Cigarette smoking is strongly associated with
an increase in coronary artery disease.
Cigarette smoking increases the relative risk
of coronary artery disease by 2.8-fold and
3.1-fold in young (35–64 years) men and
women, respectively.1 Smoking has acute
deleterious effects on the blood pressure and
sympathetic tone, and it reduces the myocar-
dial oxygen supply. Compared to non-
smokers, smokers have increased incidence
of coronary spasm and a reduced threshold
for ventricular arrhythmias.2–4 Smoking is
associated with increased ventricular prema-
ture beats, and it is a strong risk factor for
sudden cardiac death.5 However, no study
has evaluated the temporal relationship of
these electrocardiographic changes with
smoking.
There has been a growing recognition of
the importance of the autonomic nervous
system in cardiovascular disease.6 Various
measures of heart rate variability (HRV)
evaluate changes in beat-to-beat interval
durations using ambulatory ECG.7 Various
measures of HRV provide quantitative indica-
tors of cardiac autonomic function.8 Studies
have documented the increase in HRV
shortly after smoking cessation. Changes in
heart rate and HRV are also described in
association with acute passive smoking or
exposure to respirable suspended particles
(RSP). To the best of our knowledge, this is
the first report of HRV during acute expos-
ure to cigarette smoking. The objective of
ARTICLE SUMMARY
Article focus
▪ The temporal relationship of smoking with ECG
changes is not documented.
▪ This study describes the immediate effects of
smoking on heart rate, ST-segment deviation,
arrhythmias and cardiac autonomic function as
measured by heart rate variability (HRV) using
Holter monitoring.
Key messages
▪ Heart rate and ectopic beats increase acutely
following smoking.
▪ Ischaemic ST–T changes were also noted during
smoking.
▪ HRV index showed significant impairment among
smokers.
Strengths and limitations of this study
▪ First study to look at the temporal relationship of
ECG changes during smoking.
▪ Limitation—small sample size.
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this study was to evaluate the immediate effects of
smoking on heart rate, ST segment changes, arrhythmias
and cardiac autonomic function as measured by HRV
using ambulatory ECG (Holter) monitoring.
MATERIAL AND METHODS
Current smokers presenting to cardiology outpatients
unit with atypical chest pain were recruited in the study.
After a baseline examination and investigations, all the
patients underwent a treadmill exercise test. Patients
with a negative or mildly positive exercise test were
included in the study. Patients with established obstruct-
ive coronary artery disease, unstable coronary syn-
dromes, moderately positive to strongly positive exercise
test (Duke treadmill score <−11), inability to exercise,
significant arrhythmias and baseline ECG changes like
left bundle branch block and ST depression >1 mm that
preclude interpretation of treadmill exercise test (TMT)
were excluded.
All these patients underwent a 24 h Holter monitor-
ing, after providing an informed consent. The study was
approved by Institute’s ethics committee. Skin prepar-
ation, electrode placement, and related protocols were
similar to the established guidelines. Patients returned
home and maintained a normal daily routine during the
Holter monitoring. The participants were asked to
record the time of smoking and relevant symptoms.
ECGs were recorded digitally (sampling rate of 1024
samples per second) on removable flash cards using a
light-weight, 12-channel, ambulatory ECG monitor
(Delma Reynolds Life Card CF). The signal was
recorded continuously throughout the study period.
The ECG digital recordings were processed using
PC-based software (Life Card). Only normal-to-normal
beat (NN) intervals were included in the analysis. The
Holters were analysed for the minimum, maximum and
average heart rates, ST/T changes and arrhythmias.
Heart rate and ischaemic changes were specifically
noted 10 min prior to the event of smoking and every
10 min for next 60 min following every episode of
smoking. Changes during chest pain or dyspnoea or pal-
pitation and syncope were also noted. Two investigators
independently analysed all the Holter tracings.
HRV measures were calculated using time-domain
measures. The parameters of HRV measured included
SDNN (standard deviation of all NN intervals), SDANN
(standard deviation of average NN intervals during
5 min monitoring), RMSSD (root mean square value of
square differences between neighboring NN intervals),
SDNN index (mean standard deviation of all NN inter-
vals from 5 min segments), SDSD ms (standard deviation
of neighboring NN interval differences), NN 50 (count
of coupled neighboring NN intervals differing more
than 50 ms in length), p NN 50 (NN 50 divided by the
total count of NN intervals), HRV index (total count of
NN intervals divided by the histogram height) and
TINN (triangle base length gained by triangular
interpolation of histogram on the principle of smallest
square method). Statistical methods including SDNN,
SDANN and RMSSD are affected by the quality of the
QRS, but geometrical methods are free of these artifacts.
HRV index is a relative count of NN interval with most
frequently occurring length. Main advantage of geomet-
rical method resides in its independence from the
quality of analysed NN interval. Disadvantage is that it
requires long period of recording, not mere 20 min of
recording.
We used the HRV data of 15 normal participants (age-
matched to the initial 15 patients) undergoing Holter
monitoring for the control group. After the completion
of Holter, the patients were strongly counseled to quit
smoking.
Statistical analysis
The results are expressed as mean±SD or percentages.
Repeated-measures ANOVA was used to assess changes
over time and paired t tests were used to assess specific
changes. Unpaired t test or Mann-Whitney test (wher-
ever applicable) was applied for intergroup comparison
of HRV parameters. A p value of <0.05 was considered
as significant. SPSS Software V.11.0 (SPSS Inc) was used
for analysis.
RESULTS
We enrolled a total of 31 men with an average age of
49 years with approximately one-fourth of them being
bidi smokers. Bidis are cheaper Indian form of
hand-rolled cigarettes using dried betel leaves. They
contain lesser amount of tobacco, but greater concentra-
tion of nicotine as compared to regular cigarettes and
are equally harmful. The baseline characteristics are
summarised in table 1. The average heart rate through-
out the 24 h was 80.3±9.5 bpm, and the average
maximum and minimum heart rates were 119.3±15.7
and 57.5±8.9 bpm, respectively. Mean heart rate 10 min
before smoking was 83.8±13.7 bpm, which increased to
90.5±16.4 bpm on initiation of smoking and came down
Table 1 Baseline characteristic of the study patients
Characteristics Smoking group Control group
Age (years) 49.8±10.5 45.7±10.6
Male 31 (100%) 15 (100%)
Risk factors
Hypertension 5 (16%) 3 (20%)
Diabetes mellitus 1 (3%) 1 (6.7%)
Dyslipidaemia 2 (6%) 2 (13.3%)
Symptoms
Angina 5 (16%) 2 (13.3%)
Dyspnoea 5 (16%) 3 (20%)
Syncope 2 (6%) 2 (13.3%)
Presyncope 1 (3%) –
Smoking
Quantity/day 5.08±2.79 –
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to 88.2±15.3 bpm 10 min after smoking, 85.6±14.6 bpm
20 min after smoking and 84.5±14.4 bpm after 30 min of
smoking. Pair-wise comparisons of heart rate showed
that heart rate rises within 10 min of smoking and
remained elevated for the next 20 min and returned to
baseline after 30 min (table 2).
Arrhythmias per hour were analysed and correlated with
smoking episodes. Six (19.4%) patients did not have even
a single ectopic. There was significant increase in arrhyth-
mias during the hour in which cigarette was smoked and
an hour after that (figure 1). Smoking significantly
increased the total number of ectopics, summed supraven-
tricular ectopics (SVEs) and ventricular premature com-
plexes (VPCs), from a mean of 5.3/h prior to smoking to
9.8/h in the hour smoked to 11.3/h during the hour after
smoking. When the ectopics were analysed individually,
there was a significant increase in SVEs after smoking. The
mean number of SVE was 4.1/h prior to smoking, 7.1/h
during the hour of smoking and 6.9/h in the hour after
smoking (p<0.0001). However, increase in the mean
number of VPCs which was 1.2/h prior to smoking, 2.7/h
during hour of smoking and 4.3 in next hour of smoking,
did not reach statistical significance (p=0.17).
The number of patients having SVEs also increased
following smoking. SVEs occurred in 20.4% of patients
during the hour of smoking and 25.3% of patients in
the following hour as compared to 10.2% of patients in
non-smoking hours (p<0.001). However, the proportion
of patients having VPC did not change significantly.
VPCs occurred in 7.6% of patients during the hour of
smoking and 5.7% of patients in the following hour as
compared to 5.3% of patients in non-smoking hours
(p=0.17).
A run of non-sustained ventricular tachycardia
(NSVT) was recorded in one patient. NSVT developed
within 20 min of smoking; this might be related to
smoking. None of these episodes were symptomatic.
ST–T changes
Ischaemic changes were monitored during Holter
recording and correlated with the time of smoking. Of
the 31 patients, three patients (9.7%) had episodes of
significant (1–2 mm) ST segment and T wave changes in
inferior leads during and after smoking. The onset was
8–12 min after smoking and lasted for 28–120 min. One
patient had dynamic ST–T segment changes each time
he smoked. The ST segment changes did not recur
during subsequent episodes of smoking in the other
patients. No other episode of ST/T changes were noted
unrelated to smoking. A CT angiogram was performed
in the three patients with ST–T changes which did not
reveal any significant obstructive CAD.
Heart rate variability
HRV analysis was done on time domain method. HRV
parameters were within normal range, except the
HRV index (table 3). Smokers had a significantly lower
HRV index as compared to non-smoking normal controls
(15.2±5.3 in smokers vs 19.4±3.6 in healthy controls;
p value = 0.02).
DISCUSSION
Smoking is the most important risk factor for the coron-
ary artery disease. Smoking is known to have multiple
ECG effects; however, the temporal relationship of the
ECG changes to an act of smoking is not known. In the
present study, the heart rate rose within 10 min of
Table 2 Time onset of increase in heart rate from the baseline during smoking
Mean HR Mean ↑ in HR SE p Value
Prior to smoking 83.8
During smoking 90.5 6.7 1.1 <0.0001
10 min after smoking 88.2 4.4 0.7 <0.0001
20 min after smoking 85.6 1.8 0.7 0.15
30 min after smoking 84.5 0.7 0.7 0.32
Figure 1 Analysis of arrhythmias per hour prior to smoking,
hour of the smoking and in the next hour of smoking.
Table 3 HRV analysis in smokers and in normal controls
Measure Smokers (n=31) Controls (n=15) p Value
HRV index 15.2±5.3 19.4±3.6 0.02
SDNN 116.7±41.2 126.9±23.3 0.18
SDANN 109.5±42.5 116.0±17.7 0.27
RMSSD 36.1±16.9 34.9±19.9 0.67
HRV index, heart rate variability index (total count of NN intervals
divided by the histogram height); RMSSD, root mean square value
of square differences between neighboring NN intervals; SDANN,
standard deviation of average NN intervals during 5 min monitoring;
SDNN, standard deviation of all NN intervals.
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smoking and remained elevated for up to 20 min and
came to baseline after 30 min. Acute increase in heart
rate is well documented by invasive studies also.9 The
heart rate also increases following consumption of
smokeless forms of tobacco, like chewing of tobacco.10
In fact, fetal heart rates also increase following smoking
by pregnant mothers.11
Smoking acutely increased supraventricular arrhyth-
mias also. The number of SVEs per hour increased, and
also more number of smokers had SVEs recorded
during the period of smoking. Studies had shown that
smoking increases conduction velocities, and decreases
effective refractory period by decreasing parasympathetic
tone in atrial conduction system and also increases sym-
pathetic tone which could be responsible for the excess
SVEs.12 Smoking also increased ventricular arrhythmias,
but this increase did not reach statistical significance.
One of our patient developed NSVT within 20 min of
smoking. It is difficult to ascertain the cause and effect
relationship, as only a single episode was observed.
Significant ST–T changes were observed in three of
our patients. None of these three patients developed
chest pain during the ischaemic episodes. Ischaemic epi-
sodes during smoking frequently remained inert.13 14
We did not observe any episode of ST segment elevation
during or following smoking. The mechanisms by which
smoking is likely to contribute to vascular events and
ST–T changes include—induction of a hypercoagulable
state, increased myocardial work, carbon monoxide
mediated reduction in O2 carrying capacity of the
blood, induction of endothelial dysfunction, coronary
vasoconstriction and catecholamine release.15 The prog-
nostic significance of these ST–T changes in the absence
of obstructive coronary artery disease needs to be estab-
lished in smokers.
The studied HRV parameters including SDNN, SDANN
and RMSSD were within normal range, but HRV index
was significantly less in smokers. SDNN and HRV index
are the parameters expressing the overall HRV. SDANN is
a marker of spectral components with a long period and
RMSSD is a marker of components with a short
period.7 8 16 These methods do not substitute each other,
but supplant each other mutually. HRV index is a more
sensitive and specific method for HRV analysis, as it uses
geometrical method.16 As in the present study, when 24 h
of Holter is used, HRV index remains as an important par-
ameter of HRV.16
Autonomic nervous system may play an important role
in cardiovascular diseases. HRV is useful in non-invasive
quantification of autonomic nervous system.8 Large epi-
demiological studies have also linked an increased risk
of coronary artery disease, death and cardiac mortality
with decreased HRV in general populations.17 18
Although it is clear that low HRV has a negative prog-
nostic impact, it is important to point out that causality
and mechanisms have not been established. Decreased
HRV among smokers is also shown in a few studies.
A study of acute tobacco smoke exposure to small
numbers of volunteers has shown significant HRV
changes.19 Studies have also documented increase in
HRV immediately after smoking cessation.20 21 The com-
ponent of tobacco smoke that is responsible for auto-
nomic dysfunction is not known. Carbon monoxide was
implemented in some studies. Role of nicotine is still
not clear in the causation of autonomic dysfunction,
since nicotine patches that release high level of nicotine
are shown to have minimal effect on HRV. RSP may be
the main culprit. A study of healthy volunteer had
shown that 100 μg/m3 increase in 4 h RSP exposure was
associated with approximately a 25 ms decline in both
SDNN and r-MSSD.19
CONCLUSIONS
Smoking increases heart rate significantly which remains
elevated for 20 min and returns to baseline at 30 min.
It also increases combined supraventricular and ven-
tricular arrhythmias. In addition, ischaemic ST–T
changes lasting for half-an-hour to 2 h was observed
during smoking. Spectral parameters of HRV analysis of
smoker remained within normal limits, but more
importantly geometrical parameter—HRV index—
showed significant abnormality.
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